Red Light, Green Light: 2 Things to Know Before Buying Teva Pharmaceutical Industries Ltd (ADR) Stock

Shares of drugmaker Teva  (NYSE: TEVA  ) stumbled in 2013, finishing the year far behind the S&P 500.

TEVA Total Return Price Chart

TEVA Total Return Price data by YCharts

Today, however, this stock trades at an attractive multiple and could be set for a rebound in 2014. But is it smooth sailing ahead for this unique drugmaker, or are there challenges in the coming years that should worry investors? Analyst Max Macaluso explores this stock in the following video and presents one reason to avoid Teva and one reason to be optimistic about the stock's future.

3 amazing Dow dividend stock picks
If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.

Editor's Note: At 2:37, Max meant to say Teva appointed "Erez Vigodman."


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2789522, ~/Articles/ArticleHandler.aspx, 4/18/2014 12:14:46 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement